Pharmacology

Action Mechanism of Action Reference
INHIBITOR Disialoganglioside GD2 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteosarcoma 2 D012516 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL5315068
FDA SRS 7SQY4ZUD30